Question 1 of 30
A critical care unit receives a new type of reusable surgical stapler. Upon attempting to reprocess it according to the provided manufacturer\'s instructions, the sterile processing department discovers that the instructions for high-level disinfection are vague regarding the required contact time for a specific enzymatic cleaner and do not specify the maximum allowable temperature for the drying cycle. Subsequent testing reveals that the stapler\'s internal mechanisms are susceptible to degradation at temperatures exceeding 55°C, and the recommended contact time for the cleaner is insufficient to achieve the required level of microbial inactivation. Considering the principles outlined in ISO 17664:2017 and the overarching goal of patient safety, who bears the primary responsibility for the potential compromise in reprocessing effectiveness and the associated patient safety risks in this situation?
The medical device manufacturer, due to the provision of incomplete and inadequately validated reprocessing instructions.
The sterile processing department supervisor, for failing to conduct independent validation of the manufacturer's instructions.
The hospital's infection control committee, for not establishing a more stringent internal reprocessing protocol for all reusable devices.
The clinician who used the device, for not identifying the reprocessing deficiencies prior to patient use.

Preparing for ISO 17664:2017 - Processing of health care products - Information to be provided by the medical device manufacturer for the processing of medical devices? Now land the interview.

73% of qualified candidates get rejected because of weak resumes. Build an ATS-optimized, recruiter-ready resume in under 5 minutes - free to start.

Build My Resume Free